Germline variant of BRCA1 c.5332G>A has clinical features of hereditary breast and ovarian cancer syndrome-Reference-Cited by-同舟云学术

Germline variant of BRCA1 c.5332G>A has clinical features of hereditary breast and ovarian cancer syndrome

Published:2021-09-22 Issue:1 Volume:11 Page:12-16
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Saita Chiaki^ORCID,Aruga Tomoyuki,Adachi Mio,Kumaki Yuichi,Iwamoto Naoko,Yonekura Rika,Nakatsugawa Noriko,Inokuchi Takuhiko,Ishiba Toshiyuki,Honda Yayoi,Yamaguchi Tatsuro

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13691-021-00512-z.pdf

Reference15 articles.

1. Melchor L, Benitez J (2013) The complex genetic landscape of familial breast cancer. Hum Genet 132:845–863

2. National Comprehensive Cancer Network (2019) Genetic/familial high-risk assessment: breast and ovarian. Clinical practice guidelines in oncology, Version 3

3. Lindor NM, Goldgar DE, Tavtigian SV et al (2013) BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management. Oncologist 18(5):518–524

4. Kurian AW (2020) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22:72–78

5. Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222–2233

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure large-cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: The first reported case and the review of the literature;SAGE Open Medical Case Reports;2024-01

2. Pure large cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: the first reported case and the review of the literature;2023-07-18

3. Increasing our knowledge of germline variants;International Cancer Conference Journal;2022-01